Table 3 Characteristics of primary malignant cardiac tumors
From: Primary cardiac tumors on the verge of oblivion: a European experience over 15 years
Histology and location | No. of patients (% of malignant) | Tumor relapse | Distant metastasis | Mean survival (months) |
|---|---|---|---|---|
Malignant | 11 (9.7%) | 5 | 9 | 26.2 ± 9.8 |
Sarcoma (all), subtypes | 10 (91.0%), subtypes: | 5 | 8 | 21.1 ± 10.7 |
Angiosarcoma | 3 (27.3%) | 2 | 3 | 25.3 ± 17.6 |
right atrium | ||||
Intima sarcoma*** | 1 (9.1%) | 0 | 1 | 1.0 ± 0.0 |
left atrium and anterior mitral valve leaflet, obstructive | ||||
Spindle cell sarcoma | 1 (9.1%) | 1 | 0 | 7.0 ± 0.0 |
right atrium and SVC, completely obstructive | ||||
Synovial sarcoma | 1 (9.1%) | 1 | 1 | 64.00 ± 0.0 |
right atrium/ventricle, obstructing SVC/IVC | ||||
Pleomorphic sarcoma**** | 1 (9.1%) | 0 | 1 | 0.0 ± 0.0 |
left atrium, completely obstructive | ||||
Myxofibrosarcoma | 2 (18.2%) | 0 | 1 | 7.0 ± 0.0 |
left atrium | ||||
Myeloid sarcoma | 1 (9.1%) | 1 | 1 | |
right atrium, obstructing superior and inferior caval vein | ||||
NHL (DLCBL)****** | 1 (9.1%) | 0 | 1 | |
right atrium and right ventricle, obstructive |